- Home
- NRSN vs TRT Comparison
NRSN vs TRT Comparison
Compare NRSN & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- TRT
- Stock Information
- Founded
- NRSN 2017
- TRT 1958
- Country
- NRSN Israel
- TRT United States
- Employees
- NRSN N/A
- TRT N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- NRSN Health Care
- TRT Technology
- Exchange
- NRSN Nasdaq
- TRT Nasdaq
- Market Cap
- NRSN 26.0M
- TRT 22.7M
- IPO Year
- NRSN 2021
- TRT N/A
- Fundamental
- Price
- NRSN $1.18
- TRT $5.13
- Analyst Decision
- NRSN Buy
- TRT
- Analyst Count
- NRSN 2
- TRT 0
- Target Price
- NRSN $14.00
- TRT N/A
- AVG Volume (30 Days)
- NRSN 1.4M
- TRT 2.5K
- Earning Date
- NRSN 09-17-2025
- TRT 11-11-2025
- Dividend Yield
- NRSN N/A
- TRT N/A
- EPS Growth
- NRSN N/A
- TRT N/A
- EPS
- NRSN N/A
- TRT 0.00
- Revenue
- NRSN N/A
- TRT $35,548,000.00
- Revenue This Year
- NRSN N/A
- TRT N/A
- Revenue Next Year
- NRSN N/A
- TRT N/A
- P/E Ratio
- NRSN N/A
- TRT $1,225.74
- Revenue Growth
- NRSN N/A
- TRT N/A
- 52 Week Low
- NRSN $0.80
- TRT $4.62
- 52 Week High
- NRSN $2.60
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- NRSN 46.42
- TRT 40.52
- Support Level
- NRSN $1.14
- TRT $5.12
- Resistance Level
- NRSN $1.28
- TRT $5.50
- Average True Range (ATR)
- NRSN 0.15
- TRT 0.09
- MACD
- NRSN 0.03
- TRT -0.01
- Stochastic Oscillator
- NRSN 22.33
- TRT 2.63
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.